Shanghai Children's Hospital and InnovaRadi Sign Strategic Collaboration Agreement

Joining Forces with Leading Scientific Institutions to Shape a New Future for ²¹¹At Radiopharmaceuticals

InnovaRadi Therapeutics Completes First Angel Round Financing to Accelerate Development of Novel α-Emitting ²¹¹At Anticancer Radiopharmaceuticals

World's First Exploratory Clinical Trial of [²¹¹At]-MABG for High-Risk Neuroblastoma Launched